- £169.69bn
- £188.02bn
- $45.81bn
- 73
- 15
- 48
- 39
REG - AstraZeneca PLC - Half-year Report
AnnouncementREG - AstraZeneca PLC - Ultomiris recommended for EU approval for gMG
AnnouncementREG - AstraZeneca PLC - Tezspire recommended for EU approval in asthma
AnnouncementREG - AstraZeneca PLC - Enhertu granted Priority Review for HER2-low mBC
AnnouncementREG - AstraZeneca PLC - Enhertu approved in EU for HER2-positive mBC
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - AstraZeneca PLC - AstraZeneca to acquire TeneoTwo and T cell engager
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Imfinzi improved pCR in resectable lung cancer
AnnouncementREG - AstraZeneca PLC - Enhertu recommended for breast cancer EU approval
AnnouncementREG - AstraZeneca PLC - Lynparza recommended in EU for early breast cancer
AnnouncementREG - AstraZeneca PLC - Eplontersen Ph III trial met co-primary endpoints
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - AstraZeneca PLC - Enhertu efficacy results in HER2-low breast cancer
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Block listing Interim Review
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - AstraZeneca PLC - Appointment of joint corporate brokers
Announcement